casimiropt / Shutterstock.com
The EU General Court today, March 6, rejected an appeal against an European Union Intellectual Property Office (EUIPO) decision to reject the registration of a mark formerly owned by Allergan.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
EU General Court, EUIPO, trademark registration, Allergan, Serenity Pharmaceuticals, Gembro, trademark opposition, nocturia